Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. [electronic resource]
Producer: 20180201Description: 434-442 p. digitalISSN:- 1423-0410
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.